Bionure launches a crowdfunding campaign to fund the preparation the phase 2 study of BN201 Blog Post

Bionure, a biotech company specialized in neuroprotection based in the Barcelona Science Park, has launched a crowdfunding campaign through the Spanish platform of Capital Cell with the objective of raising €1.3M that will be used to finance the preparation of the phase 2 study of its neuroprotectant BN201. The campaign (multiplesmotivos.com) is part of a bridge round of €2.4M that will cover the expenses of regulatory and technical preparation of the phase 2 study.

 

ODISSeA: a pioneer initiative to improve organ donation in Southeast Asian countries Blog Post

Promoting highly specialized training for experts in the field of organ donation in Southeast Asian countries is the main aim of the training program Train the trainers, to take place from May 13 to 17 in Barcelona, under the direction of Martí Manyalich, lecturer at the Faculty of Medicine and Health Sciences of the UB and president of the DTI Foundation – Donation & Transplantation Institute, located in the Barcelona Science Park. This training initiative for physicians is part of the ODISSeA project and will finish with an institutional ceremony to take place in the Aula Magna at the Faculty of Medicine and Health Sciences of the UB on Friday, May 17.

 

GlyCardial Diagnostics receives the EmprendedorXXI Award in Catalonia Blog Post

The companies GlyCardial Diagnostics, based in the Barcelona Science Park, and Mitiga Solutions, have been honoured with the EmprendedorXXI Award in Catalonia, which is promoted by CaixaBank –through DayOne, its specialized division that provides banking services for technology and innovation companies and its investors- and awarded jointly by the Ministry of Industry, Commerce and Tourism, through Empresa Nacional de Innovación, S.A. (ENISA). The award ceremony was held yesterday in the Recinte Modernista of the Hospital de Sant Pau as part of the ‘DayOne Innovation Summit’ event. Outside of the regional prize, next May 14th the sectorial EntrepreneurXXI Awards will be awarded to 6 nationwide companies with the highest growth potential in their sector.

 

Bionure reports successful Phase 1 Study for lead candidate BN201 Blog Post

Bionure, a biotech company specialized in neuroprotection based in the Barcelona Science Park, today announces that it has successfully concluded its Phase 1 clinical study with its lead candidate BN201, a first-in-class compound to treat neurodegenerative diseases such as Multiple Sclerosis (MS). The company is now preparing a Series B funding round to finance the Phase 2 clinical program. 

 

The Bosch i Gimpera Foundation participates in five clusters in Catalonia Blog Post

The Bosch i Gimpera Foundation, based in the Barcelona Science Park, has joined the Catalan Kid’s Cluster. With the goal of encouraging contacts between research groups at the University of Barcelona and key economic players to transfer innovation to society, the foundation is also taking part in four more clusters in Catalonia: the Beauty Cluster Barcelona, the Advanced Materials Cluster of Catalonia, the Mental Health Cluster of Catalonia and the Food N’ Nutrition Cluster.  

 

Whole Genix receives the 2019 ‘Medicina Siglo XXI’ Award for Medical Innovation Blog Post

The company Whole Genix, based in the Barcelona Science Park, received the 2019 ‘Medicina Siglo XXI’ Award in the Medical Innovation category during the gala marking the II edition of these prizes, held on Friday in Hotel Arts in Barcelona. With these awards, the editorial group El Suplemento aims to value the professional, scientific and innovative talent of professionals who work for and for health in various specialties and from different Spanish cities.

 

Esteve’s R&D&I has once again received the qualification ”Excellent” in the Profarma program Blog Post

Once again, Esteve‘s research activity has received the qualification ”Excellent” in the 2018 call of the Profarma program, resolved by the Spanish Ministry of Industry, Commerce and Tourism.The pharmaceutical group – that in 2012 established its key units for the discovery of drugs and preclinical development in the Barcelona Science Park– has been recognized with the highest rating for its commitment to innovation and quality of its research.

 

Moldless approach to generate 3D intestinal tissue model using hydrogels Blog Post

The Biomimetic systems for cell engineering group, lead by Elena Martínez at IInstitute for Bioengineering of Catalonia (IBEC), has developed a new method to generate 3D intestinal tissue using hydrogels. This new in vitro model has been improved by providing cells with a more physiologically realistic environment, including tissue architecture, cell-matrix interactions and chemical signalling while remaining compatible with standard cell characterization techniques.